Instadose Pharma (Instadose Pharma) Days Payable : 0.00 (As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Days Payable?

Instadose Pharma's average Accounts Payable for the three months ended in Feb. 2022 was $1.97 Mil. Instadose Pharma's Cost of Goods Sold for the three months ended in Feb. 2022 was $0.00 Mil.

The historical rank and industry rank for Instadose Pharma's Days Payable or its related term are showing as below:

INSD's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 89.21
* Ranked among companies with meaningful Days Payable only.

Instadose Pharma's Days Payable stayed the same from Feb. 2021 (0.00) to Feb. 2022 (0.00). stayed the same

Instadose Pharma Days Payable Historical Data

The historical data trend for Instadose Pharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Days Payable Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Days Payable

Get a 7-Day Free Trial

547.50

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Instadose Pharma's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Instadose Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Instadose Pharma's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instadose Pharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Instadose Pharma's Days Payable falls into.

Instadose Pharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Instadose Pharma's Days Payable for the fiscal year that ended in Nov. 2021 is calculated as

	Days Payable (A: Nov. 2021 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Nov. 2020 )	+	Accounts Payable (A: Nov. 2021 ))	/	count )	/	Cost of Goods Sold (A: Nov. 2021 )	*	Days in Period
=	( (0	+	0.009)	/	1 )	/	0	*	365
=	0.009					/	0	*	365
=	N/A

Instadose Pharma's Days Payable for the quarter that ended in Feb. 2022 is calculated as:

	Days Payable (Q: Feb. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Nov. 2021 )	+	Accounts Payable (Q: Feb. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Feb. 2022 )	*	Days in Period
=	( (0.009	+	3.938)	/	2 )	/	0	*	365 / 4
=	1.9735					/	0	*	365 / 4
=	N/A

Instadose Pharma Days Payable Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.